Credit Agricole S A Lowered United Therapeutics Del (UTHR) Position By $322,894; Nordea Investment Management Ab Has Boosted Teva Pharmaceutical Industries Adr (TEVA) Holding By $8.32 Million

August 10, 2017 - By Louis Casey

Nordea Investment Management Ab increased Teva Pharmaceutical Industries Adr (TEVA) stake by 1.77% reported in 2016Q4 SEC filing. Nordea Investment Management Ab acquired 231,069 shares as Teva Pharmaceutical Industries Adr (TEVA)’s stock declined 15.11%. The Nordea Investment Management Ab holds 13.26M shares with $480.69 million value, up from 13.03 million last quarter. Teva Pharmaceutical Industries Adr now has $18.22 billion valuation. The stock declined 1.37% or $0.24 reaching $17.26 on the news. About 34.72 million shares traded or 85.47% up from the average. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has declined 41.70% since August 10, 2016 and is downtrending. It has underperformed by 58.40% the S&P500.

Credit Agricole S A decreased United Therapeutics Corp Del (UTHR) stake by 7.93% reported in 2016Q4 SEC filing. Credit Agricole S A sold 2,258 shares as United Therapeutics Corp Del (UTHR)’s stock declined 27.66%. The Credit Agricole S A holds 26,199 shares with $3.76 million value, down from 28,457 last quarter. United Therapeutics Corp Del now has $5.52 billion valuation. The stock declined 1.53% or $1.98 reaching $127.05 per share. About 554,050 shares traded. United Therapeutics Corporation (NASDAQ:UTHR) has risen 9.78% since August 10, 2016 and is uptrending. It has underperformed by 6.92% the S&P500.

Investors sentiment is 0.89 in 2016 Q4. Its the same as in 2016Q3. It is without change, as 34 investors sold UTHR shares while 144 reduced holdings. only 52 funds opened positions while 107 raised stakes. 45.07 million shares or 3.04% less from 46.49 million shares in 2016Q3 were reported. Commerzbank Aktiengesellschaft Fi has 41,207 shares. Sumitomo Mitsui Tru reported 0.03% of its portfolio in United Therapeutics Corporation (NASDAQ:UTHR). Federated Incorporated Pa has 203,609 shares for 0.09% of their portfolio. Weaver C Barksdale And Associate stated it has 0.01% in United Therapeutics Corporation (NASDAQ:UTHR). Alphamark Advsr Ltd holds 0% or 50 shares in its portfolio. Pensionfund Dsm Netherlands owns 23,000 shares for 0.48% of their portfolio. Putnam Invs Ltd Liability Company holds 0.01% or 39,275 shares. Moreover, Sumitomo Mitsui Asset Management has 0.01% invested in United Therapeutics Corporation (NASDAQ:UTHR). Utah Retirement, Utah-based fund reported 8,065 shares. Winfield Associates accumulated 5 shares or 0% of the stock. Amalgamated Bank stated it has 0.05% in United Therapeutics Corporation (NASDAQ:UTHR). Evercore Wealth Mngmt Limited Liability Corp stated it has 0% of its portfolio in United Therapeutics Corporation (NASDAQ:UTHR). Los Angeles Equity Rech, California-based fund reported 230,527 shares. Legal & General Gru Public Ltd Co holds 51,778 shares or 0.01% of its portfolio. Bancorp Of America De holds 0% of its portfolio in United Therapeutics Corporation (NASDAQ:UTHR) for 103,481 shares.

Credit Agricole S A increased Lyondellbasell Industries N V (NYSE:LYB) stake by 116,281 shares to 2.41 million valued at $206.49 million in 2016Q4. It also upped Aflac Inc (NYSE:AFL) stake by 17,993 shares and now owns 168,698 shares. Coca Cola European Partners P was raised too.

Among 12 analysts covering United Therapeutics (NASDAQ:UTHR), 2 have Buy rating, 4 Sell and 6 Hold. Therefore 17% are positive. United Therapeutics had 20 analyst reports since July 29, 2015 according to SRatingsIntel. The firm has “Neutral” rating given on Wednesday, June 15 by H.C. Wainwright. On Friday, July 31 the stock rating was maintained by Argus Research with “Buy”. Standpoint Research downgraded the shares of UTHR in report on Thursday, January 19 to “Hold” rating. The firm earned “Neutral” rating on Thursday, February 23 by Ladenburg Thalmann. The rating was downgraded by Ladenburg Thalmann to “Neutral” on Friday, April 29. On Friday, July 28 the stock rating was maintained by H.C. Wainwright with “Hold”. The firm earned “Buy” rating on Friday, October 28 by Ladenburg Thalmann. RBC Capital Markets maintained United Therapeutics Corporation (NASDAQ:UTHR) rating on Wednesday, July 29. RBC Capital Markets has “Sector Perform” rating and $175 target. The company was downgraded on Tuesday, November 29 by Barclays Capital. As per Tuesday, May 24, the company rating was downgraded by Argus Research.

Since February 16, 2017, it had 0 buys, and 15 insider sales for $2.60 million activity. 1,261 shares were sold by ROTHBLATT MARTINE A, worth $152,225 on Thursday, May 18. $278,740 worth of United Therapeutics Corporation (NASDAQ:UTHR) was sold by Thompson Tommy G on Wednesday, March 22.